Therapeutic Intravascular Ultrasound (TIVUS) Renal Denervation System for the Adjunctive Treatment of Hypertension

What is the Purpose of this Study?

The purpose of this study is to evaluate the safety and effectiveness of an experimental device called the TIVUS System to treat people who have hypertension (high blood pressure) that is not controlled despite treatment with blood pressure medications. Individuals with controlled blood pressure who are willing to come off their blood pressure medications for the purpose of being in this study may also participate. The study aims to determine whether the device, which uses sound waves (ultrasonic energy) to heat up and impair some of the nerves around the arteries leading to the kidneys, will control blood pressure as well as or better than using medication. The information collected from this study will be used to evaluate how well participants do when treated with the TIVUS system both immediately after treatment and over a longer period of time (3 years). Procedures include angiograms, ultrasounds, blood and urine collection, and a possible procedure in which an ultrasound catheter is placed in the kidney’s main artery to deliver a short pulse of heat. Participants will be randomly assigned to either the treatment group using the TIVUS system or to the sham group (no treatment). For every 2 patients treated with TIVUS system, 1 will be assigned to the sham group; participants will have approximately a 67% chance of receiving treatment with the TIVUS system. Blood pressure-lowering medications will eventually be restarted during the study, and participants who received the sham procedure may have the chance to receive renal denervation with the TIVUS system after approximately 6 months of study participation.


Eligibility

  • 1. Appropriately signed and dated informed consent
  • 2. Male and female adults with age between ≥22 and ≤75 years at time of consent
  • 3. Documented history of hypertension
  • 4. Previously or currently prescribed antihypertensive therapy
Show more

Where can I participate?

Beverly

More about this Clinical Trial

What is the full name of this clinical trial?

A Pivotal, Prospective, Multicenter, 2:1 Randomized, Double Blind, Controlled, Study Comparing the Therapeutic Intravascular Ultrasound Renal Denervation System vs. Sham for the Adjunctive Treatment of Hypertension .

Study Details
Disease Type/Condition

Hypertension

Principal Investigator

Rader, Florian

Age Group

Adult

Phase

N/A

IRB Number

STUDY00003691

ClinicalTrials.gov ID

NCT06559891

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Hypertension

Principal Investigator

Rader, Florian

Age Group

Adult

Phase

N/A

IRB Number

CLNS07001

ClinicalTrials.gov ID

NCT06559891

Key Eligibility
ClinicalTrials.gov

Contact
Email
clinicaltrials@cshs.org